GE Healthcare, Medtronic receive FDA 510(k) clearance and CE Mark approval on the integration of advanced INVOS regional oximetry and Microstream capnography technologies on the CARESCAPE precision
It could potentially help guide heart failure therapy to avert acute decompensations, researchers say. But of course, we have to show that now in larger and randomized clinical studies.
RACECAT trial results suggest the longer travel times to the comprehensive stroke center rather than going to a closer primary stroke center could be harmful for patients having a hemorrhagic stroke.